Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-Face Comparison of Microneedle Patch Versus Botulinum Toxin-A Plus Microneedle Patch for Undereye Skin Texture
TCTR20231002007Phase 3Completed
- Sponsor
- Thammasat University
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in cutaneous aging, sponsored by Thammasat University. Started Sep 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cutaneous aging
Beyond the preview
Go deeper on TCTR20231002007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231002007.